Orchard Therapeutics PLC Sponsored ADR Free Cash Flow 2019-2023 | ORTX
Orchard Therapeutics PLC Sponsored ADR free cash flow from 2019 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Orchard Therapeutics PLC Sponsored ADR Annual Free Cash Flow |
| 2022 |
-82.50 |
| 2021 |
-127.45 |
| 2020 |
-128.94 |
| 2019 |
-170.50 |
| 2018 |
-101.57 |
| 2017 |
-34.05 |
| 2016 |
-14.76 |
| Orchard Therapeutics PLC Sponsored ADR Quarterly Free Cash Flow |
| 2023-09-30 |
-81.84 |
| 2023-06-30 |
-57.82 |
| 2023-03-31 |
-30.02 |
| 2022-12-31 |
-82.50 |
| 2022-09-30 |
-69.93 |
| 2022-06-30 |
-47.55 |
| 2022-03-31 |
-20.00 |
| 2021-12-31 |
-127.45 |
| 2021-09-30 |
-93.66 |
| 2021-06-30 |
-76.23 |
| 2021-03-31 |
-39.58 |
| 2020-12-31 |
-128.94 |
| 2020-09-30 |
-116.99 |
| 2020-06-30 |
-90.50 |
| 2020-03-31 |
-51.23 |
| 2019-12-31 |
-170.50 |
| 2019-09-30 |
-126.74 |
| 2019-06-30 |
-73.71 |
| 2019-03-31 |
-44.29 |
| 2018-12-31 |
-101.57 |
| 2018-09-30 |
-75.71 |
| 2018-06-30 |
-43.91 |
| 2018-03-31 |
-16.90 |
